Tatva Chintan Pharma Chem Limited
NSE:TATVA.NS
856.35 (INR) • At close November 4, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||||||
| Nettowinst
| 52.09 | 96.14 | 34.55 | 77.81 | 95.04 | 169.59 | 116.23 | 71.12 | 97.97 | 175.1 | 228.07 | 324.12 | 231.46 | 211.19 | 208.75 | 35.56 | 67.1 |
| Afschrijvingen & Amortisatie
| 0 | 0 | 65.83 | 67.77 | 60.12 | 25.31 | 23.83 | 23.08 | 0 | 0 | 0 | 0 | 0 | 17.6 | 0 | 0 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -338.13 | 0 | 0 | 0 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -333.21 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.75 | 0 | 0 | 0 |
| Crediteuren
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.83 | 0 | 0 | 0 |
| Overige Niet-Contante Posten
| -52.09 | -96.14 | -34.55 | -77.81 | -95.04 | -169.59 | -116.23 | -71.12 | -97.97 | -175.1 | -228.07 | -324.12 | -231.46 | 78.68 | -208.75 | -35.56 | -67.1 |
| Kasstroom uit Operationele Activiteiten
| 0 | 0 | 131.66 | 135.54 | 120.24 | 50.62 | 47.66 | 46.16 | 0 | 0 | 0 | 0 | 0 | -30.66 | 0 | 0 | 0 |
| Investeringsactiviteiten: | |||||||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -103.31 | 0 | 0 | 0 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.9 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -104.21 | 0 | 0 | 0 |
| Financieringsactiviteiten: | |||||||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32.44 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127.6 | 0 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.16 | 0 | 0 | 0 |
| Overige Informatie: | |||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 84.52 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 0 | 0 | 131.66 | 135.54 | 120.24 | 50.62 | 47.66 | 46.16 | 0 | 0 | 0 | 0 | 0 | 44.81 | 0 | 0 | 0 |
| Kaspositie aan het Einde van de Periode
| 0 | 0 | 1,569.14 | 1,437.48 | 429.35 | 309.11 | 934.47 | 886.81 | 0 | 0 | 0 | 0 | 44.81 | 44.81 | 0 | 0 | 0 |